Search
Search Results
##search.searchResults.foundPlural##
-
PERIOPERATIVE MANAGEMENT OF SICKLE CELL DISEASE: A NARRATIVE REVIEW
7817PDF: 3174HTML: 1174 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4535PDF: 2730HTML: 2244 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2162PDF: 926HTML: 1869 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3137PDF: 974HTML: 1989 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1068PDF: 459HTML: 211 -
CD48 AS A NOVEL EARLY BIOMARKER COMPLEMENTING PROCALCITONIN AND LACTATE FOR PREDICTING BACTEREMIA IN PEDIATRIC FEBRILE NEUTROPENIA: A PROSPECTIVE COHORT STUDY CD48 A NOVEL EARLY BIOMARKER PREDICTING BACTERIEMIA
738PDF: 469HTML: 92 -
POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.
557PDF: 274Suppl. Files: 102HTML: 95 -
DYNAMIC MONITORING OF ADAMTS 13 ACTIVITY FOR DIFFERENTIAL DIAGNOSIS ACROSS THE SPECTRUM OF SEPSIS ASSOCIATED WITH THROMBOTIC MICROANGIOPATIES Adamts 13 and Sepsis Associated with Thrombotic Thrombocytopenic Purpura
537PDF: 337HTML: 74 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1426PDF: 894HTML: 208 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12240PDF: 1629HTML: 4141Cover letter: 181Figure 1: 175 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2326PDF: 824HTML: 2440 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
1868PDF: 770HTML: 204 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
788PDF: 523HTML: 4003 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2433PDF: 817HTML: 8787Efremov 1: 205Efremov 2: 165 -
ASSESSMENT OF THE EFFICACY OF PROCALCITONIN, C-REACTIVE PROTEIN AND ALBUMIN LEVELS-GUIDED ANTIBIOTICS USE IN SEPSIS
863PDF: 440Html: 128Suppl. Files: 146 -
ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY
2076PDF: 1298HTML: 3487 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
704PDF: 453HTML: 6246 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2250PDF: 1542HTML: 579 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
2757PDF: 1536HTML: 216 -
FASTING PLASMA GLUCOSE LEVELS WITHIN THE HIGH NORMAL RANGE ARE ASSOCIATED WITH A SIGNIFICANTLY INCREASED RISK OF FUTURE DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β THALASSEMIA: A DECADE-LONG MULTICENTER RETROSPECTIVE ANALYSIS Higher normal fasting plasma glucose and glucose dysregulation in β- thalassemia
543PDF: 179Html: 24 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4128PDF: 1486HTML: 426 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4241PDF: 1448HTML: 1531Untitled: 210







